In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.
LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.
A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?
At Thailand’s Vivo Bene Dementia Resort, pampering is the priority. This special report for 60 MINUTES asks, why can’t there be facilities like Vivo Bene in Australia?
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
Lecanemab, the newest Alzheimer’s drug, is getting a boost by focusing ultrasound waves on the blood-brain barrier. Learn more about this next step in delivering better Alzheimer’s treatments.
The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.
Nanodevices are the newest weapon in medicine’s growing arsenal to fight Alzheimer’s. They capture dangerous peptides before they can assemble to form Alzheimer’s plaques in the brain.
CLINICAL TRIALS VIDEO: Thin electrical wires were surgically implanted in the brain of Alzheimer’s patients. Called “Deep Brain Stimulation”, see how this brain “pacemaker” improves
Denise Medved is the founder and creator of a program that takes Alzheimer’s patients through vigorous, spirited exercise routines. She calls her program, “Ageless Grace”.
Learn about ‘personalized music for dementia’ and its powerful effect on Alzheimer’s. See the Director of the hit film, ‘Alive Inside’, on the dementia-impact of music.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.
No spam, only news and updates.
